Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women

Menopause

Volumn 16, Issue 2, 2009, Pages 395-400

  Charles, Cornelia ^a   Yuskavage, Julia ^a   Carlson, Olga ^a   John, Majnu ^b   Tagalicud, Arlene S ^a   Maggio, Marcello ^a   Muller, Denis C ^a   Egan, Josephine ^a   Basaria, Shehzad ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Adipokines; Cytokines; Insulin resistance; Isoflavones

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; CYTOKINE; ESTROGEN; GHRELIN; GLUCOSE; INSULIN; ISOFLAVONE DERIVATIVE; PLACEBO; SOYBEAN PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NORMAL HUMAN; POSTMENOPAUSE;

ADIPOKINES; BLOOD GLUCOSE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; MIDDLE AGED; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 67649349916     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181857979     Document Type: Article

References (29)

1. McKinlay SM. The normal menopause transition: an overview. Maturitas 1996;23:137-145.
2. Landgren B-M, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 2004;89: 2763-2769.
3. Tamakoshi K, Yatsuya H, Wada K, et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol 2007;66:65-71.
4. Chu MC, Cospe P, Orio F, Crmina E, Lobo R. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, and ghrelin. Am J Obstet Gynecol 2006;194:100-104.
5. Budak E, Sanchez MF, Bellver J, Cervero A, Simon C, Pellicer A. Interactions of hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril 2006;85:1563-1581.
6. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
7. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-613.
8. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-333.
9. Murkies A, Wilcox G, Davis S. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 1998;83:297-303.
10. Knight DC, Eden J. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-904.
11. Baird D, Umbach D, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-1690.
12. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Diabetes and risk factors in second- and third-generation Japanese Americans in Seattle, Washington. Diabetes Res Clin Pract 1994;24:S43-S52.
13. Fujimoto WY, Leonetti DL, Bergstrom RW, Kinyoun JL, Stolov WC, Wahl PW. Glucose intolerance and diabetic complications among Japanese-American women. Diabetes Res Clin Pract 1991;13:119-129.
14. Azadbakht L, Kimiagar M, Mehrabi Y, et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 2007;85: 735-741.
15. Jayagopal V, Jennings P, Albertazzi P, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002;25:1709-1714.
16. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
17. Basaria S, Wisniewski A, Dupree K, et al. Effects of high-dose isoflavones on cognition, quality of life, androgens and lipoprotiens in postmenopausal women. J Endocrinol Ivest. In press.
18. Gaspard UJ, Gottel JM, Van Den Brule AF. Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas 1995;21:171-178.
19. Espeland M, Schrott H, Hogan P, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 1998;21:1589-1595.
20. Andersson B, Mattsson LA, Hahn L, et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:638-643.
21. Brown MD, Korytkowski MT, Zmuda JM, McCole SD, Moore GE, Hagberg JM. Insulin sensitivity in postmenopausal women: independent and combined associations with hormone replacement, cardiovascular fitness, and body composition. Diabetes Care 2000;23: 1731-1736.
22. Duncan A, Phipps W, Kurzer M. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 2003;17:253-271.
23. Huang Y, Cao S, Nagamani M, Anderson KE, Grady JJ, Lu LJ. Decreased circulating levels of tumor necrosis factor-α in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 2005;90:3956-3962.
24. Nikander E, Tiitinen M, Ylikorkala O. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 2003; 88:5180-5185.
25. Chen Z, Zheng W, Custer LJ, et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavones in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1998;33:82-87.
26. Kleijn JJM, Van der Scouw Y, Wilson P, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham Study. J Nutr 2001;131:1826-1832.
27. Vedavanam K, Srijayanta S, O'Reilly J, Raman, Wiseman H. Antioxidant action and potential antidiabetic properties of an iso-flavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 1999;13:601-608.
28. Nikander E, Tiitinen A, Laitinen K, Tikkanen M, Ylikorkala O. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab 2004;89: 3567-3572.
29. Arnr P. Insulin resistance in type 2 diabetes - role of the adipokines. Curr Mol Med 2005;5:333-339.